SW209049
CAS No. 1673558-59-2
SW209049( —— )
Catalog No. M37687 CAS No. 1673558-59-2
SW209049 is a stearoyl-CoA 9-desaturase inhibitor. SW209049 exhivits potent activity against H2122 cell with IC50 of 0.13uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 170 | In Stock |
|
| 5MG | 153 | In Stock |
|
| 10MG | 225 | In Stock |
|
| 25MG | 337 | In Stock |
|
| 50MG | 465 | In Stock |
|
| 100MG | 625 | In Stock |
|
| 200MG | 828 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSW209049
-
NoteResearch use only, not for human use.
-
Brief DescriptionSW209049 is a stearoyl-CoA 9-desaturase inhibitor. SW209049 exhivits potent activity against H2122 cell with IC50 of 0.13uM.
-
DescriptionSW209049 is a stearoyl-CoA 9-desaturase inhibitor. SW209049 exhivits potent activity against H2122 cell with IC50 of 0.13uM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
RecptorDehydrogenase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1673558-59-2
-
Formula Weight442.49
-
Molecular FormulaC25H18N2O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(C(=O)C1=CC=C(C(=O)C2=CC=C(OCC#C)C=C2)C=C1)C3=NC=4C(S3)=CC(OC)=CC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
CAY10566
CAY10566 shows excellent cellular activity in blocking the conversion of saturated long-chain fatty acid-CoAs (LCFA-CoAs) to monounsaturated LCFA-CoAs in HepG2 cells (IC50=7.9 nM or 6.8 nM). CAY10566 is a potent, orally bioavailable and selective stearoyl-CoA desaturase1 (SCD1) inhibitor with IC50s of 4.5 and 26 nM in mouse and human enzymatic assays, respectively.
-
Tenuifoliside B
Tenuifoliside B is a natural?product from? the roots of Polygala tenuifolia.And is?a target lactate dehydrogenase inhibitor.?Tenuifoliside B has cognitive improving and cerebral protective effects.?it can inhibit potassium cyanide (KCN)-induced hypoxia and scopolamine-induced memory impairment in mice.
-
AGI-14100
AGI-14100 is a novel and orally available mIDH1 inhibitor.AGI-14100 is used for the treatment of primary human myeloid leukemia.
Cart
sales@molnova.com